Group 2:Rivaroxaban

3 trials

Sponsors

Shanghai Pulmonary Hospital, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

Conditions

Atrial FibrillationPost-thrombotic Syndromevenous thromboembolism

Phase 4

Effect of gene polymorphism on the efficacy of direct oral anticoagulant therapy in patients with venous thromboembolism

Active, not recruitingChiCTR1800019890

Shanghai Pulmonary Hospitalvenous thromboembolism

Start: 2019-01-01Updated: 2018-12-10

Oral Direct Factor Xa Inhibitor (Rivaroxaban) in Patients With Post-thrombotic Syndrome (PTS) after Stent Implantation

Active, not recruitingChiCTR1800020395

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of MedicinePost-thrombotic Syndrome

Start: 2019-01-01Updated: 2019-01-14

Randomized controlled study of different antithrombotic strategies after occlusion of left atrial appendage with LACbes occluder

RecruitingChiCTR2100046712

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of MedicineAtrial Fibrillation

Start: 2023-02-01Updated: 2023-02-13

Related Papers

Different antithrombotic strategies after left atrial appendage closure with the LACbes occluder: protocol of the DAAL trial

BMJ Open2025-03-01